Zebra Technologies
ZBRA
$327.44
+1.89%
Zebra Technologies is the world's largest provider of automatic identification and data capture (AIDC) technology, selling barcode printers and scanners, mobile computers, RFID and machine-vision hardware, and increasingly a software layer for workflow optimization into retail, transportation and logistics, manufacturing, and healthcare verticals. Its competitive identity rests on an installed base of tens of thousands of enterprise customers and a razor-and-blade dynamic in supplies and services that makes it the de facto standard for frontline operational data capture rather than a pure hardware vendor. The current investor narrative has pivoted sharply toward a cyclical recovery plus AI-enabled hardware refresh story: management just posted record Q3 results and raised full-year revenue growth guidance to roughly 17%, with commentary pointing to AI-capable devices, successful price increases to offset memory cost inflation, and a large acquired software/asset-intelligence asset folded into the portfolio. The debate now centers on whether the demand surge is a durable multi-year upgrade cycle or a pull-forward that will collide with margin pressure from component costs and a leveraged balance sheet, a tension reflected in the stock's violent post-earnings gap higher followed by a sharp November give-back.…
ZBRA
Zebra Technologies
$327.44
Related headlines
Investment Opinion: Should I buy ZBRA Today?
Rating: Buy, with moderate conviction. The core thesis is that Zebra's record Q3 revenue of $1.614 billion (+22.27% YoY) and raised ~17% full-year growth guidance represent a genuine cyclical recovery plus AI-enabled hardware refresh, while the stock at $322.02 trades at only 14.48x forward earnings against a $415.25 average analyst target implying ~29% upside — and even the lowest $350 target sits 8.7% above the current price. The 10 Buy / 6 Hold / 0 Sell consensus (recommendation mean 1.94) reinforces that the Street views the 16.59% one-month drawdown as a dislocation rather than fundamental deterioration.
The supporting evidence is unusually asymmetric for a hardware name: forward PE of 14.48x versus 29.47x trailing implies earnings roughly doubling to the $29.90 consensus EPS, PS of 2.29x sits near the bottom of a multi-year band that ran 11-15x in 2024-2025, and TTM free cash flow of $988 million ($300 million in Q3 alone) covers quarterly capex of just $24 million by 13.5x. Revenue has grown sequentially every quarter of 2026 ($1.495B → $1.557B → $1.614B), and the company repaid $199 million of debt in Q3 while continuing buybacks. Against a 45.9% trailing gross margin and 14.8% operating margin, the 17.62x EV/EBITDA is not a software-like premium — the market is pricing cyclicality and leverage, not optimism.
The biggest risks that could invalidate the thesis are (1) gross margin, which fell 727 basis points from 52.99% in Q2 to 45.72% in Q3 as memory cost inflation outran price pass-through; (2) balance-sheet tightness, with a current ratio of 0.97 and cash down to $182 million from $1.053 billion a year earlier after the ~$1.3 billion acquisition; and (3) the possibility that the AI upgrade cycle is a pull-forward rather than a durable multi-year demand surge. The rating would upgrade to a high-conviction Buy if gross margin stabilizes above 46-47% for two consecutive quarters and the stock reclaims the $361-377 late-October shelf; it would downgrade to Hold if gross margin slides toward 43% or revenue growth decelerates below 15%. On balance the stock looks undervalued relative to its growth rate and its own history — the 2.29x PS and 3.44x PB are near multi-year lows — but the negative PEG of -1.50 and elevated EV/EBITDA mean the cheapness partly reflects cyclicality rather than pure mispricing, so this is a data-driven Buy rather than a table-pounding one.
Sign up to view all
ZBRA 12-Month Price Forecast
The forward view is constructive but not complacent: Zebra combines a 22% revenue growth trajectory and a 14.5x forward multiple with unanimous analyst upside, which historically has been a favorable setup for a cyclical recovery trade. The offsetting factor is margin quality — a 727 basis point gross margin step-down in Q3 shows memory cost inflation is real, and the sub-1.0 current ratio limits the balance sheet's ability to absorb further shocks. Analyst sentiment is stable rather than momentum-driven (all recent notes are reiterations, with 6 of 15 Holds reflecting valuation and cyclicality caution), and the $415 average target may not yet fully reflect Q3 margin compression. I would upgrade to high confidence if gross margin holds above 46-47% for two consecutive quarters and the stock reclaims the $361-377 late-October shelf; I would downgrade to neutral if gross margin slides toward 43% or revenue growth decelerates below 15%, which would suggest the upgrade cycle was a pull-forward.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Zebra Technologies's 12-month outlook, with a consensus price target around $413.45 and implied upside of +26.3% versus the current price.
Average Target
$413.45
16 analysts
Implied Upside
+26.3%
vs. current price
Analyst Count
16
covering this stock
Price Range
$350 - $455
Analyst target range
Coverage is robust with 15 analysts and a clearly bullish tilt: 10 Buy ratings, 6 Hold, and 0 Sell, yielding a consensus recommendation of "buy" and a recommendation mean of 1.94 (where 1.0 is a strong buy). The average target price of $415.25 implies roughly 29% upside from the current $322.02, and notably even the lowest target of $350.00 sits about 8.7% above the current price, meaning the entire published range is above the market. That unanimity of upside is a strong signal that the recent 16.6% monthly selloff is viewed on the Street as a dislocation rather than a fundamental deterioration, consistent with the post-Q3 pattern of reiterated Overweight/Outperform ratings from Barclays, BNP Paribas, and Needham.
The target range of $350.00 to $455.00 is moderately wide (a 30% spread from low to high), signaling meaningful dispersion in assumptions about the durability of the AI-driven upgrade cycle and margin recovery. The $455 high target likely assumes multiple expansion back toward the mid-teens forward PE on the $29.90 consensus EPS plus successful pass-through of memory costs, while the $350 low target probably capitalizes a scenario of gross margin staying near 45%, slower 2027 growth, and continued deleveraging drag. Institutional actions show stability rather than momentum: recent notes are overwhelmingly reiterations (Barclays Overweight, Citigroup Neutral, Morgan Stanley Equal Weight, Truist Hold, Needham Buy, TD Cowen Buy) with no visible downgrades, and the Hold-heavy minority (6 of 15) reflects lingering caution on valuation and cyclicality rather than bearish conviction. The key risk to the consensus is that the $415 average target was likely set before the November drawdown and may not yet fully reflect the margin compression visible in Q3.
Bulls vs Bears: ZBRA Investment Factors
The bull case currently has stronger evidence: revenue is accelerating at 22% YoY with raised guidance, free cash flow is robust at $988 million TTM, and the entire analyst target range ($350-$455) sits above the current $322.02 price, implying the Street sees the November drawdown as a dislocation. However, the bear case is not weak — gross margin compressed nearly 730 basis points from Q2 to Q3 (52.99% to 45.72%), the current ratio has slipped below 1.0, and short-term momentum has decisively broken with the stock trailing SPY by 11.6 points over one month. The single most important tension is whether the AI-driven hardware upgrade cycle is a durable multi-year demand surge or a pull-forward that will collide with memory cost inflation and a leveraged balance sheet. How gross margin resolves over the next two quarters — holding above the mid-40s versus sliding toward 43% — is the factor that will most change the thesis, since it determines whether the 14.5x forward PE is genuinely cheap or a value trap.
Bullish
- Revenue accelerating at 22% YoY: Q3 2026 revenue hit a record $1.614 billion, up 22.27% from $1.320 billion a year earlier, with sequential growth every quarter ($1.495B → $1.557B → $1.614B). Management raised full-year growth guidance to roughly 17%, signaling demand visibility extending into 2027 rather than a one-quarter spike.
- Forward PE of 14.5x is undemanding: The stock trades at just 14.48x forward earnings versus 29.47x trailing, a 51% compression implying the market expects earnings to roughly double to the $29.90 consensus EPS. For a business growing revenue 22%, a mid-teens forward multiple leaves substantial room for re-rating if the recovery executes.
- Entire analyst range sits above price: With 10 Buy, 6 Hold, and 0 Sell ratings, the $415.25 average target implies ~29% upside, and even the lowest $350 target is 8.7% above the current $322.02. That unanimity of upside suggests the Street views the 16.6% monthly selloff as a dislocation rather than fundamental deterioration.
- Strong free cash flow and deleveraging: TTM free cash flow is $988 million, including $300 million in Q3 alone, against just $24 million of quarterly capex (13.5x coverage). The company repaid $199 million of debt in Q3 while continuing buybacks, demonstrating the balance sheet can self-fund operations despite the ~$1.3 billion acquisition.
Bearish
- Gross margin compressing sharply: Gross margin fell to 45.72% in Q3 from 52.99% in Q2 and 49.63% in Q1, while operating margin dropped to 14.68% from 20.62%. Memory cost inflation is only partially offset by price hikes, and the 45.9% trailing gross margin leaves limited cushion if component costs keep rising.
- Leveraged balance sheet with thin liquidity: Debt-to-equity is 0.78 and the current ratio is 0.97, below 1.0, indicating modest liquidity tightness. Cash fell to $182 million from $1.053 billion a year earlier after the ~$1.3 billion acquisition plus $568 million of buybacks, constraining further M&A or aggressive repurchases.
- Momentum has broken down: The stock is down 16.59% over the past month and 14.47% over three months, trailing SPY by 11.60 and 9.56 percentage points respectively, despite a +24.70% one-year return. At $322.02 it sits 18.0% below its 52-week high, and a decisive break below $320 would target the $290-300 breakout base.
- High beta amplifies downside: With a beta of 1.633, Zebra is roughly 63% more volatile than the S&P 500, meaning a 10% market decline could translate into a mid-teens drawdown. The -36.51% max drawdown underscores that position sizing must account for outsized swings, especially with sticky inflation keeping rate cuts off the table.
ZBRA Technical Analysis
Zebra is in a powerful but newly tested uptrend: the stock is up 24.70% over the past year and 29.69% year-to-date, and at $322.02 it sits at roughly 65% of its 52-week range of $199.05 to $392.78, having surrendered a meaningful chunk of the upper band. The 6-month gain of 42.47% versus a flat SPY (-0.54%) shows the trend was decisively market-leading through the summer, but the current price is 18.0% below the 52-week high, placing the stock in a corrective phase within a still-intact longer-term advance rather than at momentum highs. That positioning argues against chasing strength here and instead frames the pullback as either a constructive reset or the early stage of a trend break, depending on whether prior support holds.
Short-term momentum has deteriorated sharply and now diverges from the annual trend: the stock is down 16.59% over the past month and 14.47% over three months, versus a +24.70% one-year return, a classic deceleration pattern. Relative strength confirms the underperformance, with ZBRA trailing SPY by 11.60 percentage points over one month and 9.56 points over three months, even though it still leads by 15.11 points over twelve months and 43.01 points over six months. The most recent session was essentially flat (+0.12%, +$0.38 on 777,502 shares), suggesting selling pressure may be exhausting near $320, but the absence of a decisive reversal candle after a 16.6% monthly drawdown means momentum remains negative and RSI is likely in weak-neutral to oversold territory rather than confirming a bottom.
Key technical levels are well defined: support sits at the $321.64 prior close and the $329.50-332.44 gap zone from early November, with the more meaningful floor at the 52-week low of $199.05, while resistance is the $392.78 52-week high and the $391.00 October peak that capped the prior rally. A reclaim of $361-377 (the late-October shelf) would signal the correction is over and reopen the path to new highs, whereas a decisive break below $320 would target the $290-300 breakout base from late July and, if that fails, put the 52-week low back in play. With a beta of 1.633, Zebra is roughly 63% more volatile than the S&P 500, and its -36.51% max drawdown underscores that position sizing must account for outsized swings; a 1.6 beta means a 10% market decline could translate into a mid-teens drawdown for ZBRA.
Beta
1.63
1.63x market volatility
Max Drawdown
-36.5%
Largest decline past year
52-Week Range
$199-$393
Price range past year
Annual Return
+28.3%
Cumulative gain past year
| Period | ZBRA Return | S&P 500 |
|---|---|---|
| 1m | -15.6% | -2.4% |
| 3m | -13.7% | -2.3% |
| 6m | +26.3% | +2.8% |
| 1y | +28.3% | +11.3% |
| ytd | +31.9% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ZBRA Fundamental Analysis
Revenue is accelerating impressively: Q3 2026 (period ended October 3) revenue reached $1.614 billion, up 22.27% year-over-year from $1.320 billion, and the sequential cadence of $1.495 billion in Q1, $1.557 billion in Q2, and $1.614 billion in Q3 shows steady quarter-over-quarter expansion on top of a tough prior-year base. Segment disclosure shows Enterprise Visibility & Mobility at $865 million and Asset Intelligence & Tracking at $455 million, with the EVM franchise (mobile computing and scanning) the larger growth engine while AIT (printers, supplies, and the acquired asset-visibility software) provides recurring, higher-margin ballast. The trajectory implies full-year revenue near the $7.44 billion consensus estimate, and the fact that management raised guidance to ~17% growth mid-year signals demand visibility extending into 2027, though the deceleration from 22% YoY in Q3 toward guided full-year growth is the key thing to monitor.
Profitability is solid but margin quality is uneven: Q3 net income was $164 million on a 10.16% net margin, down from Q2's $233 million and 14.96% margin, while gross margin compressed to 45.72% from 52.99% in Q2 and 49.63% in Q1, and operating margin fell to 14.68% from 20.62%. The Q2 gross margin spike looks anomalous (possibly one-time pricing or mix benefits), and the Q3 step-down to 45.72% is consistent with the 45.9% trailing gross margin and management's commentary about memory cost inflation partially offset by price hikes. Trailing net margin of 7.77% and operating margin of 14.83% are respectable for a hardware-led AIDC vendor but well below software peers, and the 45.9% gross margin leaves limited cushion if component costs keep rising; the key question is whether pricing power can keep gross margin above the mid-40s through the upgrade cycle.
Balance sheet and cash generation are adequate but not fortress-like: debt-to-equity is 0.78, the current ratio is 0.97 (below 1.0, indicating modest liquidity tightness), and cash fell to $182 million at Q3-end from $1.053 billion a year earlier, largely due to the ~$1.3 billion acquisition in Q4 2025 plus $300 million and $268 million of buybacks in Q1 and Q2 2026. Free cash flow remains healthy at $988 million TTM and $300 million in Q3 alone, with operating cash flow of $324 million against just $24 million of capex (a 13.5x capex coverage ratio), and ROE of 11.68% and ROA of 7.51% are reasonable though below the company's historical mid-teens ROE. The combination of positive FCF, active deleveraging ($199 million repaid in Q3), and continued buybacks suggests the company can self-fund operations, but the sub-1.0 current ratio and reduced cash buffer mean external financing or further debt paydown will constrain aggressive M&A or large repurchases near term.
Quarterly Revenue
$1.6B
2026-10
Revenue YoY Growth
+22.3%
YoY Comparison
Gross Margin
45.7%
Latest Quarter
Free Cash Flow
$988000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ZBRA Overvalued?
Because Zebra is solidly profitable (Q3 net income of $164 million, TTM EPS positive), the PE ratio is the appropriate primary metric. The stock trades at 29.47x trailing earnings but only 14.48x forward earnings, a dramatic 51% compression that implies the market expects earnings to roughly double; that gap is consistent with the analyst consensus EPS estimate of $29.90 for the forward period versus a trailing figure distorted by the low-margin 2025 quarters and acquisition-related charges. The forward multiple of 14.5x is undemanding in absolute terms for a company growing revenue 22%, which is the core of the bull case, though the trailing PE of 29.5x and PEG of -1.50 (negative because of the depressed trailing earnings base) show how sensitive the story is to execution on the earnings recovery.
Against its own sector and history, Zebra screens cheap on sales but expensive on cash flow: the PS ratio of 2.29x and EV/Sales of 2.89x are low for a Technology/Communication Equipment name, while EV/EBITDA of 17.62x and price-to-free-cash-flow of 13.46x (P/CF) sit in a middle range. The 3.44x price-to-book and 45.9% gross margin versus a 14.8% operating margin suggest the market is not paying a software-like premium, and the 2.29x PS is well below the 8-15x PS multiples Zebra carried in 2024-2025 when its revenue base was smaller and growth slower, implying the multiple has compressed even as the business improved. On balance the stock looks inexpensive relative to its growth rate, but the negative PEG and elevated EV/EBITDA versus a 17.6x reading argue that the cheapness is partly a reflection of cyclicality and leverage rather than a pure mispricing.
Historical context is instructive: Zebra's trailing PE ranged from roughly 14.4x (Q2 2026) to 43.7x (Q4 2025) and 207x at the 2023 earnings trough, while its PS ratio has collapsed from 11-15x in 2024-2025 to 2.29x today, near the bottom of its multi-year band. The current 29.5x trailing PE is mid-range historically, but the 2.29x PS and 3.44x PB are near multi-year lows, and the 14.5x forward PE is among the cheapest readings in the dataset. That combination suggests the market is pricing in skepticism about the durability of the earnings recovery and the acquisition integration, which creates asymmetric upside if margins stabilize, but also warns that the multiple is unlikely to re-rate until gross margin compression is demonstrably arrested.
PE
29.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 14x~44x
vs. Industry Avg
33.6x
Industry PE ~33.6x*
EV/EBITDA
17.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin compression and balance-sheet tightness. Gross margin fell from 52.99% in Q2 to 45.72% in Q3, a 727 basis point step-down, while operating margin dropped from 20.62% to 14.68%, showing that memory cost inflation is outpacing price pass-through. The current ratio of 0.97 (below 1.0) and cash of just $182 million versus $1.053 billion a year earlier — after a ~$1.3 billion acquisition and $568 million of buybacks — mean the company has limited liquidity buffer if component costs keep rising or the upgrade cycle stalls. Revenue concentration in the EVM segment ($865 million of $1.614 billion Q3 revenue) adds cyclicality, and the 10.16% net margin is well below software peers, leaving little cushion for execution missteps.
Market and competitive risks are amplified by valuation sensitivity and high beta. At a beta of 1.633, Zebra is roughly 63% more volatile than the S&P 500, so a 10% market decline could produce a mid-teens drawdown; with sticky inflation keeping Fed rate cuts off the table, high-valuation tech names face multiple compression pressure. The stock already trails SPY by 11.60 points over one month and 9.56 points over three months, and the 17.62x EV/EBITDA versus a 14.8% operating margin suggests the market is not paying a software-like premium but is also not pricing in much margin recovery. Competitive disruption from lower-cost AIDC vendors and the risk that the AI-enabled hardware refresh is a pull-forward rather than a durable cycle could trigger further analyst caution, especially since the $415 average target was likely set before the November drawdown and may not yet reflect Q3 margin compression.
The worst-case scenario is a chain in which memory cost inflation persists, gross margin slides toward 43%, the upgrade cycle proves to be a pull-forward, and the leveraged balance sheet limits the company's ability to defend margins through pricing or buybacks. In that scenario, the stock could retest its 52-week low of $199.05, which would represent a decline of roughly 38% from the current $322.02 — consistent with the -36.51% max drawdown already experienced. Even a less severe bear case aligning with the analyst low target of $350 would actually be above the current price, so the realistic downside is defined by the 52-week low rather than the published target range; investors should size positions assuming a potential -35% to -38% drawdown to $199-210 if the margin recovery fails.
FAQ
Ranked by severity, the first risk is margin compression: gross margin fell 727 basis points from 52.99% in Q2 to 45.72% in Q3 as memory cost inflation outran price pass-through, and the 45.9% trailing gross margin leaves little cushion. Second is balance-sheet tightness: the current ratio is 0.97 (below 1.0), cash fell to $182 million from $1.053 billion a year earlier after the ~$1.3 billion acquisition and $568 million of buybacks, and debt-to-equity is 0.78, limiting the ability to absorb further cost shocks. Third is cyclical and competitive risk: the AI hardware refresh could prove a pull-forward, and lower-cost AIDC vendors could pressure pricing just as the EVM segment ($865 million of Q3 revenue) carries the growth load. Fourth is macro and market risk: a 1.633 beta means a 10% S&P decline could translate into a mid-teens drawdown, and with sticky inflation keeping rate cuts off the table, high-multiple tech faces multiple compression — already visible in the -36.51% historical max drawdown.
The 12-month forecast is split into three scenarios. The base case (50% probability, $400-$430) assumes ~17% full-year revenue growth near the $7.44 billion consensus, gross margin holding in the mid-40s, and forward EPS tracking $29.90, driving the stock toward the $415.25 average target — about 29% upside. The bull case (30%, $440-$455) requires gross margin recovering above 47% and multiple expansion toward the mid-teens forward PE plus upward EPS revisions, reaching the $455 high target (41% upside). The bear case (20%, $199-$260) assumes margin slides toward 43%, the upgrade cycle proves a pull-forward, and the leveraged balance sheet limits defense, retesting the $199.05 52-week low (-38%). The base case is most likely, and its key assumption is that memory cost pass-through holds and gross margin stabilizes rather than continuing to erode.
The stock screens undervalued on forward earnings and sales but only fairly valued on cash flow. At 14.48x forward EPS versus 29.47x trailing, the market is implicitly pricing earnings roughly doubling to the $29.90 consensus, a 51% compression that is steep for a company growing revenue 22.27%. The 2.29x PS and 3.44x PB sit near multi-year lows, well below the 11-15x PS Zebra carried in 2024-2025, while 17.62x EV/EBITDA and 13.46x price-to-cash-flow are mid-range rather than cheap. The negative PEG of -1.50 is an artifact of a depressed trailing earnings base (Q4 2025 EPS of $1.39 and Q1 2026 of $2.68), not a genuine red flag, but it does show how dependent the valuation is on the recovery executing. Net, the market is paying a discount to Zebra's own history and to its growth rate, implying skepticism about margin durability and acquisition integration — which is the source of the asymmetry if gross margin stabilizes.
From a risk/reward standpoint the setup is favorable but not risk-free: at $322.02 the stock sits 29% below the $415.25 average analyst target and even the $350 low target is 8.7% above the current price, with 10 Buy, 6 Hold, and 0 Sell ratings. The valuation support is the 14.48x forward PE against a $29.90 consensus EPS and a 2.29x PS near multi-year lows, while $988 million of TTM free cash flow and $199 million of Q3 debt repayment show the business self-funds. The biggest downside is margin: gross margin fell from 52.99% in Q2 to 45.72% in Q3, and a slide toward 43% could send the stock back toward its $199.05 52-week low, roughly -38%. It is a good buy for investors with a 12-24 month horizon who can stomach a 1.633 beta and size positions for a potential 35% drawdown, and a poor fit for anyone needing near-term momentum, given the -16.59% one-month move and -11.60 point relative underperformance versus SPY.
Zebra is better suited to a medium-to-long-term holding than to short-term trading. It pays no dividend (0% yield, 0% payout), so returns depend entirely on price appreciation and the earnings recovery, and its 1.633 beta plus -36.51% max drawdown make it a poor vehicle for tight-stop short-term trading — the -16.59% one-month and -14.47% three-month moves show how violently it can swing around earnings. The growth stage is a mature cyclical in an AI-driven refresh, with earnings visibility supported by raised ~17% full-year guidance and $988 million of TTM free cash flow, which favors patience through the margin normalization. A concrete minimum holding period of 12-24 months is appropriate, long enough to capture two to four quarters of gross margin data and the Q4 2026 report, and investors should size positions assuming a potential 35-38% drawdown to the $199-210 range if the margin recovery fails.